Neurology

NICE recommends natalizumab for the treatment of multiple sclerosis

The National Institute for Health and Clinical Excellence (NICE) has today issued guidance recommending natalizumab for the treatment of rapidly evolving severe relapsing-remitting multiple sclerosis (RES). This guidance is produced as part of its rapid single technology appraisal (STA) work programme.
Read more

 http://www.nice.org.uk/page.aspx?o=449477...

National Institute for Health and Clinical Excellence